JWH-359: Difference between revisions
Content deleted Content added
claim not supported by reference |
No edit summary |
||
| Line 23: | Line 23: | ||
{{cannabinoid-stub}} |
{{cannabinoid-stub}} |
||
==External links== |
|||
* www.titaniumwf.com Manufacture and Sale |
|||
==References== |
==References== |
||
Revision as of 20:13, 6 November 2010
 | |
| Identifiers | |
|---|---|
| |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H36O2 |
| Molar mass | 356.540 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
JWH-359 is a dibenzopyran "classical" cannabinoid drug, which is a potent and selective CB2 receptor agonist, with a Ki of 13.0nM and selectivity of around 220x for CB2 over CB1 receptors. It is related to other dibenzopyran CB2 agonists such as JWH-133 and L-759,656 but with a chiral side chain which has made it useful in mapping the shape of the CB2 binding site.[1][2]. It was discovered by, and named after, Dr. John W. Huffman.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
External links
- www.titaniumwf.com Manufacture and Sale
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16165365, please use {{cite journal}} with
|pmid=16165365instead. - ^ http://www.ncbi.nlm.nih.gov/pubmed/18289088